WBDE(SZ:002082)2020-04-28 16:00Financial Performance - The company's operating revenue for Q1 2020 was ¥2,560,392,088.56, representing a decrease of 24.98% compared to the same period last year[7]. - Net profit attributable to shareholders was ¥47,805,036.95, an increase of 6.82% year-on-year[7]. - The net profit after deducting non-recurring gains and losses was ¥47,659,201.22, which is a 27.95% increase compared to the previous year[7]. - Basic earnings per share were ¥0.08, up 14.29% from ¥0.07 in the previous year[7]. - The company's total operating revenue for Q1 2020 was ¥2,560,392,088.56, a decrease of 25.0% compared to ¥3,412,871,865.36 in Q1 2019[43]. - Net profit for Q1 2020 was ¥49,491,336.90, representing an increase of 4.9% from ¥47,188,230.17 in Q1 2019[45]. - The total comprehensive income attributable to the parent company was CNY 13,357,284.50, compared to CNY 40,930,826.07 in the previous period[46]. Cash Flow - The net cash flow from operating activities was -¥141,562,471.46, a significant decline of 601.12% compared to the same period last year[7]. - The net cash flow from financing activities increased by 83.12% year-on-year, primarily due to an increase in borrowing scale[15]. - The net increase in cash and cash equivalents decreased by 114.45% year-on-year, mainly due to a decrease in net cash flow from operating activities[15]. - The company reported a total cash inflow from operating activities of CNY 2,498,384,039.47, down from CNY 3,880,257,775.96 in the previous year[52]. - The cash outflow from investing activities was CNY 227,376,506.71, compared to CNY 168,516,704.27 in the previous period[53]. - The net cash flow from financing activities was a negative CNY 4,273,702.99, compared to a negative CNY 25,310,709.94 in the previous year[54]. - The cash inflow from sales of goods and services was 241,410,355.00 CNY, up from 164,049,207.33 CNY in the previous period, showing improved sales performance[56]. Assets and Liabilities - Total assets at the end of the reporting period were ¥5,082,547,159.25, a decrease of 0.93% from the end of the previous year[7]. - The company's total assets as of March 31, 2020, amounted to ¥2,477,131,647.89, up from ¥1,743,972,249.10 at the end of 2019[41]. - The company's total liabilities increased to CNY 2.37 billion from CNY 2.28 billion, marking an increase of approximately 3.5%[37]. - The total liabilities decreased to ¥450,541,966.12 in Q1 2020 from ¥574,293,312.77 at the end of 2019, a decline of 21.6%[41]. - The company's total assets amounted to 5,130,291,784.03 CNY, with total liabilities at 2,278,578,941.67 CNY, indicating a healthy asset-to-liability ratio[61]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 24,553[11]. - The largest shareholder, Wanbang Group Co., Ltd., held 31.46% of the shares, amounting to 194,466,282 shares[11]. - The total equity attributable to shareholders of the parent company was ¥2,497,563,384.65, down from ¥2,556,800,454.68 at the end of 2019[40]. - The company's equity increased significantly, with share capital rising to CNY 618.22 million from CNY 238 million, indicating a substantial increase[37]. Operational Changes - The company completed the acquisition of Wanbang Pharmaceutical, which became a wholly-owned subsidiary on February 4, 2020[23]. - The company implemented new revenue and lease standards starting from 2020, with retrospective adjustments for prior comparative data not applicable[64]. - The company reported no non-operating fund occupation by controlling shareholders or related parties during the reporting period[29]. - There were no significant investments in securities, entrusted wealth management, or derivative investments during the reporting period[25][26][27]. Other Financial Metrics - The company's R&D expenses for Q1 2020 were ¥24,155,529.29, a decrease of 13.5% compared to ¥27,995,678.39 in Q1 2019[44]. - Other income decreased by 75.81% year-on-year, mainly due to a decline in government subsidies related to the company's daily operations[15]. - Asset impairment losses increased by 219.24 million yuan year-on-year, primarily due to the provision for inventory write-downs in the current period[15]. - The company's other comprehensive income for Q1 2020 was -¥58,900,696.31, compared to -¥5,085,821.95 in Q1 2019[45].